http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
원저 : 헬리코박터 파일로리의 3차 구제요법에서 리파부틴과 레보플록사신의 비교
정명호 ( Myung Ho Jeong ),정준원 ( Jun Won Chung ),이상진 ( Sang Jin Lee ),하민수 ( Minsu Ha ),정석후 ( Seok Hoo Jeong ),나선영 ( Sunyoung Na ),나병수 ( Byung Soo Na ),박성근 ( Sung Keun Park ),김윤재 ( Yoon Jae Kim ),권광안 ( Kwa 대한소화기학회 2012 대한소화기학회지 Vol.59 No.6
Background/Aims: There is increasing need for third-line therapy of Helicobacter pylori due to increasing level of antibiotics resistance. The aim of this study was to compare rifabutin and levofloxacin rescue regimens in patients with first- and second-line Helicobacter pylori eradication failures. Methods: Patients, in whom a first treatment with proton pump inhibitor-clarithromycin-amoxicillin and a second trial with proton pump inhibitor-bismuth-tetracycline-metronidazole had failed, received treatment with either rifabutin or levofloxacin, plus amoxicillin (1 g twice daily) and standard dose proton pump inhibitor. Eradication rates were confirmed with 13C-urea breath test or rapid urease test 4 weeks after the cessation of therapy. Results: Eradication rates were 71.4% in the rifabutin group, and 57.1% in the levofloxacin group, respectively. Although there was no significant difference in Helicobacter pylori eradication rates between two groups (p=0.656), rifabutin based regimen showed relatively higher eradication rate. Conclusions: Helicobacter pylori eradication rates of rifabutin- or levofloxacin-based triple therapy could not achieve enough eradication rate. Further studies would be needed on combination of levofloxacin and rifabutin-based regimen or culture based treatment. (Korean J Gastroenterol 2012;59:401-406)